Acquisitions of Hospice Agencies by Private Equity Firms and Publicly Traded Corporations
Over the past 3 decades, the hospice industry has transitioned from a mostly not-for-profit sector to one where nearly two-thirds of all agencies operate on a for-profit basis. A substantial driver of this trend has been the growth of large for-profit hospice chains, many of which are part of public...
Gespeichert in:
| Veröffentlicht in: | Archives of internal medicine (1960) 2021-08, Vol.181 (8), p.1113-1114 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1114 |
|---|---|
| container_issue | 8 |
| container_start_page | 1113 |
| container_title | Archives of internal medicine (1960) |
| container_volume | 181 |
| creator | Braun, Robert Tyler Stevenson, David G Unruh, Mark Aaron |
| description | Over the past 3 decades, the hospice industry has transitioned from a mostly not-for-profit sector to one where nearly two-thirds of all agencies operate on a for-profit basis. A substantial driver of this trend has been the growth of large for-profit hospice chains, many of which are part of publicly traded corporations (PTCs). In general, for-profit hospice agencies have been associated with higher rates of live discharge, lower levels of skilled staffing, and provision of a narrower range of clinical services than nonprofit agencies.1,3,4 An understudied and less visible factor is the more recent entry of private equity (PE) investment into the sector. Facilitated by relatively easy market entry and the prospect of stable Medicare payments, PE firms and PTCs have made strategic hospice investments in recent years, raising quality concerns among some policymakers and patient advocates. In this study, we measure the prevalence of hospice agency acquisitions by PE firms and PTCs over the period from 2011 to 2019. |
| doi_str_mv | 10.1001/jamainternmed.2020.6262 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_ama_p</sourceid><recordid>TN_cdi_proquest_miscellaneous_2521494793</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>2779069</ama_id><sourcerecordid>2521494793</sourcerecordid><originalsourceid>FETCH-LOGICAL-a394t-98eaf67da36dad69bfe42ae75efd014982b03a5ed6892932cbaed27dc8d98cbc3</originalsourceid><addsrcrecordid>eNqNkU9LHDEYh4fSUkX9Aj20gV4KZdf8mckkl8IyaBWEetBDTyGTvGOzzCRrMqPst2_W1aF6ai4J5Pn9eJOnKL4QvCQYk9O1HrTzI0Q_gF1STPGSU07fFYeUcLHghJTv5zPmB8VJSmucl8C4ZOxjccCYZEISeVj8Xpn7ySU3uuATCh26CGnjDKDVHXjjIKF2i66je9AjoLOMjlt07uKQkPYWXU9t70y_RTdRW7CoCXETon4qOy4-dLpPcPK8HxW352c3zcXi6tfPy2Z1tdBMluNCCtAdr61m3GrLZdtBSTXUFXQWk1IK2mKmK7BcSCoZNa0GS2trhJXCtIYdFT_2vZupzf9hwI9R92oT3aDjVgXt1Osb7_6ou_CgBJYlpiIXfHsuiOF-gjSqwSUDfa89hCkpWtE8R1lLltGvb9B1mKLPz8sUJxWpGa4yVe8pE0NKEbp5GILVzqB6ZVDtDKqdwZz8_O9b5tyLrwx83wOP0IYuZUHewIxlxbysRVmRnW2SafH_dOPGJ3FNmPyYo5_20TzpnKB1LTGX7C_GdMaZ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2561517305</pqid></control><display><type>article</type><title>Acquisitions of Hospice Agencies by Private Equity Firms and Publicly Traded Corporations</title><source>MEDLINE</source><source>American Medical Association Journals</source><source>Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><creator>Braun, Robert Tyler ; Stevenson, David G ; Unruh, Mark Aaron</creator><creatorcontrib>Braun, Robert Tyler ; Stevenson, David G ; Unruh, Mark Aaron</creatorcontrib><description>Over the past 3 decades, the hospice industry has transitioned from a mostly not-for-profit sector to one where nearly two-thirds of all agencies operate on a for-profit basis. A substantial driver of this trend has been the growth of large for-profit hospice chains, many of which are part of publicly traded corporations (PTCs). In general, for-profit hospice agencies have been associated with higher rates of live discharge, lower levels of skilled staffing, and provision of a narrower range of clinical services than nonprofit agencies.1,3,4 An understudied and less visible factor is the more recent entry of private equity (PE) investment into the sector. Facilitated by relatively easy market entry and the prospect of stable Medicare payments, PE firms and PTCs have made strategic hospice investments in recent years, raising quality concerns among some policymakers and patient advocates. In this study, we measure the prevalence of hospice agency acquisitions by PE firms and PTCs over the period from 2011 to 2019.</description><identifier>ISSN: 2168-6106</identifier><identifier>EISSN: 2168-6114</identifier><identifier>DOI: 10.1001/jamainternmed.2020.6262</identifier><identifier>PMID: 33938919</identifier><language>eng</language><publisher>CHICAGO: American Medical Association</publisher><subject><![CDATA[Delivery of Health Care - economics ; Delivery of Health Care - methods ; Efficiency, Organizational ; Financial Management - methods ; Financial Management - trends ; General & Internal Medicine ; Health Care Policy and Law ; Hospice care ; Hospices - economics ; Hospices - organization & administration ; Hospitals, Proprietary ; Humans ; Letters ; Life Sciences & Biomedicine ; Market entry ; Medicare - economics ; Medicare - statistics & numerical data ; Medicine, General & Internal ; Online First ; Palliative care ; Private equity ; Research Letter ; Science & Technology ; Transparency ; United States]]></subject><ispartof>Archives of internal medicine (1960), 2021-08, Vol.181 (8), p.1113-1114</ispartof><rights>Copyright American Medical Association Aug 2021</rights><rights>Copyright 2021 American Medical Association. All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>14</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000647845100001</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-a394t-98eaf67da36dad69bfe42ae75efd014982b03a5ed6892932cbaed27dc8d98cbc3</citedby><cites>FETCH-LOGICAL-a394t-98eaf67da36dad69bfe42ae75efd014982b03a5ed6892932cbaed27dc8d98cbc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jamainternalmedicine/articlepdf/10.1001/jamainternmed.2020.6262$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.6262$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,230,315,782,786,887,3344,27933,27934,39267,76499,76502</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33938919$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Braun, Robert Tyler</creatorcontrib><creatorcontrib>Stevenson, David G</creatorcontrib><creatorcontrib>Unruh, Mark Aaron</creatorcontrib><title>Acquisitions of Hospice Agencies by Private Equity Firms and Publicly Traded Corporations</title><title>Archives of internal medicine (1960)</title><addtitle>JAMA INTERN MED</addtitle><addtitle>JAMA Intern Med</addtitle><description>Over the past 3 decades, the hospice industry has transitioned from a mostly not-for-profit sector to one where nearly two-thirds of all agencies operate on a for-profit basis. A substantial driver of this trend has been the growth of large for-profit hospice chains, many of which are part of publicly traded corporations (PTCs). In general, for-profit hospice agencies have been associated with higher rates of live discharge, lower levels of skilled staffing, and provision of a narrower range of clinical services than nonprofit agencies.1,3,4 An understudied and less visible factor is the more recent entry of private equity (PE) investment into the sector. Facilitated by relatively easy market entry and the prospect of stable Medicare payments, PE firms and PTCs have made strategic hospice investments in recent years, raising quality concerns among some policymakers and patient advocates. In this study, we measure the prevalence of hospice agency acquisitions by PE firms and PTCs over the period from 2011 to 2019.</description><subject>Delivery of Health Care - economics</subject><subject>Delivery of Health Care - methods</subject><subject>Efficiency, Organizational</subject><subject>Financial Management - methods</subject><subject>Financial Management - trends</subject><subject>General & Internal Medicine</subject><subject>Health Care Policy and Law</subject><subject>Hospice care</subject><subject>Hospices - economics</subject><subject>Hospices - organization & administration</subject><subject>Hospitals, Proprietary</subject><subject>Humans</subject><subject>Letters</subject><subject>Life Sciences & Biomedicine</subject><subject>Market entry</subject><subject>Medicare - economics</subject><subject>Medicare - statistics & numerical data</subject><subject>Medicine, General & Internal</subject><subject>Online First</subject><subject>Palliative care</subject><subject>Private equity</subject><subject>Research Letter</subject><subject>Science & Technology</subject><subject>Transparency</subject><subject>United States</subject><issn>2168-6106</issn><issn>2168-6114</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>HGBXW</sourceid><sourceid>EIF</sourceid><recordid>eNqNkU9LHDEYh4fSUkX9Aj20gV4KZdf8mckkl8IyaBWEetBDTyGTvGOzzCRrMqPst2_W1aF6ai4J5Pn9eJOnKL4QvCQYk9O1HrTzI0Q_gF1STPGSU07fFYeUcLHghJTv5zPmB8VJSmucl8C4ZOxjccCYZEISeVj8Xpn7ySU3uuATCh26CGnjDKDVHXjjIKF2i66je9AjoLOMjlt07uKQkPYWXU9t70y_RTdRW7CoCXETon4qOy4-dLpPcPK8HxW352c3zcXi6tfPy2Z1tdBMluNCCtAdr61m3GrLZdtBSTXUFXQWk1IK2mKmK7BcSCoZNa0GS2trhJXCtIYdFT_2vZupzf9hwI9R92oT3aDjVgXt1Osb7_6ou_CgBJYlpiIXfHsuiOF-gjSqwSUDfa89hCkpWtE8R1lLltGvb9B1mKLPz8sUJxWpGa4yVe8pE0NKEbp5GILVzqB6ZVDtDKqdwZz8_O9b5tyLrwx83wOP0IYuZUHewIxlxbysRVmRnW2SafH_dOPGJ3FNmPyYo5_20TzpnKB1LTGX7C_GdMaZ</recordid><startdate>20210801</startdate><enddate>20210801</enddate><creator>Braun, Robert Tyler</creator><creator>Stevenson, David G</creator><creator>Unruh, Mark Aaron</creator><general>American Medical Association</general><general>Amer Medical Assoc</general><scope>BLEPL</scope><scope>DTL</scope><scope>HGBXW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210801</creationdate><title>Acquisitions of Hospice Agencies by Private Equity Firms and Publicly Traded Corporations</title><author>Braun, Robert Tyler ; Stevenson, David G ; Unruh, Mark Aaron</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a394t-98eaf67da36dad69bfe42ae75efd014982b03a5ed6892932cbaed27dc8d98cbc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Delivery of Health Care - economics</topic><topic>Delivery of Health Care - methods</topic><topic>Efficiency, Organizational</topic><topic>Financial Management - methods</topic><topic>Financial Management - trends</topic><topic>General & Internal Medicine</topic><topic>Health Care Policy and Law</topic><topic>Hospice care</topic><topic>Hospices - economics</topic><topic>Hospices - organization & administration</topic><topic>Hospitals, Proprietary</topic><topic>Humans</topic><topic>Letters</topic><topic>Life Sciences & Biomedicine</topic><topic>Market entry</topic><topic>Medicare - economics</topic><topic>Medicare - statistics & numerical data</topic><topic>Medicine, General & Internal</topic><topic>Online First</topic><topic>Palliative care</topic><topic>Private equity</topic><topic>Research Letter</topic><topic>Science & Technology</topic><topic>Transparency</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Braun, Robert Tyler</creatorcontrib><creatorcontrib>Stevenson, David G</creatorcontrib><creatorcontrib>Unruh, Mark Aaron</creatorcontrib><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Archives of internal medicine (1960)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Braun, Robert Tyler</au><au>Stevenson, David G</au><au>Unruh, Mark Aaron</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acquisitions of Hospice Agencies by Private Equity Firms and Publicly Traded Corporations</atitle><jtitle>Archives of internal medicine (1960)</jtitle><stitle>JAMA INTERN MED</stitle><addtitle>JAMA Intern Med</addtitle><date>2021-08-01</date><risdate>2021</risdate><volume>181</volume><issue>8</issue><spage>1113</spage><epage>1114</epage><pages>1113-1114</pages><issn>2168-6106</issn><eissn>2168-6114</eissn><abstract>Over the past 3 decades, the hospice industry has transitioned from a mostly not-for-profit sector to one where nearly two-thirds of all agencies operate on a for-profit basis. A substantial driver of this trend has been the growth of large for-profit hospice chains, many of which are part of publicly traded corporations (PTCs). In general, for-profit hospice agencies have been associated with higher rates of live discharge, lower levels of skilled staffing, and provision of a narrower range of clinical services than nonprofit agencies.1,3,4 An understudied and less visible factor is the more recent entry of private equity (PE) investment into the sector. Facilitated by relatively easy market entry and the prospect of stable Medicare payments, PE firms and PTCs have made strategic hospice investments in recent years, raising quality concerns among some policymakers and patient advocates. In this study, we measure the prevalence of hospice agency acquisitions by PE firms and PTCs over the period from 2011 to 2019.</abstract><cop>CHICAGO</cop><pub>American Medical Association</pub><pmid>33938919</pmid><doi>10.1001/jamainternmed.2020.6262</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2168-6106 |
| ispartof | Archives of internal medicine (1960), 2021-08, Vol.181 (8), p.1113-1114 |
| issn | 2168-6106 2168-6114 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2521494793 |
| source | MEDLINE; American Medical Association Journals; Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /> |
| subjects | Delivery of Health Care - economics Delivery of Health Care - methods Efficiency, Organizational Financial Management - methods Financial Management - trends General & Internal Medicine Health Care Policy and Law Hospice care Hospices - economics Hospices - organization & administration Hospitals, Proprietary Humans Letters Life Sciences & Biomedicine Market entry Medicare - economics Medicare - statistics & numerical data Medicine, General & Internal Online First Palliative care Private equity Research Letter Science & Technology Transparency United States |
| title | Acquisitions of Hospice Agencies by Private Equity Firms and Publicly Traded Corporations |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T11%3A19%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_ama_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acquisitions%20of%20Hospice%20Agencies%20by%20Private%20Equity%20Firms%20and%20Publicly%20Traded%20Corporations&rft.jtitle=Archives%20of%20internal%20medicine%20(1960)&rft.au=Braun,%20Robert%20Tyler&rft.date=2021-08-01&rft.volume=181&rft.issue=8&rft.spage=1113&rft.epage=1114&rft.pages=1113-1114&rft.issn=2168-6106&rft.eissn=2168-6114&rft_id=info:doi/10.1001/jamainternmed.2020.6262&rft_dat=%3Cproquest_ama_p%3E2521494793%3C/proquest_ama_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2561517305&rft_id=info:pmid/33938919&rft_ama_id=2779069&rfr_iscdi=true |